Milk-and-cheese diet in portal-systemic encephalopathy.

作者信息

Fenton J C, Knight E J, Humpherson P L

出版信息

Lancet. 1966 Jan 22;1(7430):164-6. doi: 10.1016/s0140-6736(66)90696-9.

DOI:10.1016/s0140-6736(66)90696-9

PMID:4159095

Abstract

摘要

相似文献

Milk-and-cheese diet in portal-systemic encephalopathy.

Lancet. 1966 Jan 22;1(7430):164-6. doi: 10.1016/s0140-6736(66)90696-9.

Subtotal portacaval shunt obliteration for chronic hepatic encephalopathy.

Ann Surg. 1973 Mar;177(3):276-9. doi: 10.1097/00000658-197303000-00006.

[The role of total colectomy in portacaval encephalopathy].

J Chir (Paris). 1972 May-Jun;103(5):437-50.

[Acidophilus milk in dietary treatment of liver cirrhosis with encephalopathy].

Nord Med. 1971 Aug 19;86(33):969-73.

Hepatic coma in cirrhosis, portal hypertension, and following portacaval shunt. Its etiologies and the current status of its treatment.

Arch Surg. 1974 Mar;108(3):325-36. doi: 10.1001/archsurg.1974.01350270055010.

Reversal of behavioral changes in rats subjected to portacaval shunt with oral neomycin therapy.

Hepatology. 1994 May;19(5):1245-50.

[Changes in the levels of ammonia and free phenols in patients with portocaval shunt treated with lactulose and/or neomycin compared to a low protein diet (author's transl)].

Med Klin. 1978 Jan 13;73(2):63-8.

Surgical treatment of chronic portal-systemic encephalopathy.

Arch Surg. 1968 Feb;96(2):269-73. doi: 10.1001/archsurg.1968.01330200107022.

Treatment of hepatic coma.

Am J Gastroenterol. 1969 Feb;51(2):118-28.

Long-term treatment of portal-systemic encephalopathy with lactulose.

Australas Ann Med. 1969 May;18(2):117-23. doi: 10.1111/imj.1969.18.2.117.

引用本文的文献

Role of Microbiota-Derived Metabolites in Alcoholic and Non-Alcoholic Fatty Liver Diseases.

Int J Mol Sci. 2021 Dec 31;23(1):426. doi: 10.3390/ijms23010426.

A Comprehensive Review Evaluating the Impact of Protein Source (Vegetarian vs. Meat Based) in Hepatic Encephalopathy.

Nutrients. 2021 Jan 26;13(2):370. doi: 10.3390/nu13020370.

Dietary approach and gut microbiota modulation for chronic hepatic encephalopathy in cirrhosis.

World J Hepatol. 2019 Jun 27;11(6):489-512. doi: 10.4254/wjh.v11.i6.489.

EASL Clinical Practice Guidelines on nutrition in chronic liver disease.

J Hepatol. 2019 Jan;70(1):172-193. doi: 10.1016/j.jhep.2018.06.024. Epub 2018 Aug 23.

Nutritional issues in patients with obesity and cirrhosis.

World J Gastroenterol. 2018 Aug 14;24(30):3330-3346. doi: 10.3748/wjg.v24.i30.3330.

Repeated Measures of Blood and Breath Ammonia in Response to Control, Moderate and High Protein Dose in Healthy Men.

Sci Rep. 2018 Feb 7;8(1):2554. doi: 10.1038/s41598-018-20503-0.

Protein restriction in hepatic encephalopathy is appropriate for selected patients: a point of view.

Hepatol Int. 2014 Sep 1;8(2):447-51. doi: 10.1007/s12072-013-9497-1.

Progress in the treatment of chronic portasystemic encephalopathy.

Gut. 1984 Jan;25(1):85-98. doi: 10.1136/gut.25.1.85.

Treatment of hepatic encephalopathy.

Postgrad Med J. 1969 Mar;45(521):227-9. doi: 10.1136/pgmj.45.521.227.

The pathogenesis and medical treatment of hepatic encephalopathy.

Postgrad Med J. 1968 Aug;44(514):652-6. doi: 10.1136/pgmj.44.514.652.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验